In these videos, Sushila Dulal, MD, associate professor of medicine at the University Chicago of Medicine, discusses the latest treatments, state of the pipeline and unmet needs for patients with ...

In these videos, Sushila Dulal, MD, associate professor of medicine at the University Chicago of Medicine, discusses the latest treatments, state of the pipeline and unmet needs for patients with ...

Upadacitinib showed promising results in achieving clinical and endoscopic remission in people with moderate to severe Crohn ...

A breakdown of Crohn’s disease, its symptoms, causes, and long-term impact on health. Explore the causes, symptoms, diagnosis ...

A recent study by Yuya Ogino and colleagues created a scoring model for early Crohn's disease (CD) diagnosis based on results ...

Irritable bowel syndrome (IBS) can mimic some symptoms of inflammatory bowel disease (IBD). Learn how their causes, diagnosis ...

Agomab Therapeutics NV (?Agomab') today announced that interim data from the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule inhibitor ...

Crohn's disease is a chronic inflammatory bowel disease ... He is also the director of the Third Space Endoscopy program for the Center for Interventional Gastroenterology (iGUT) at UTHealth ...

A Phase 2a, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of AGMB-129 in Patients with Fibrostenotic Crohn’s Disease: Interim ...

That now may be possible for at least one disease. Around 1 million Americans contend with Crohn’s disease — an inflammatory autoimmune condition that can affect the digestive tract, and cause ...

That now may be possible for at least one disease. Around 1 million Americans contend with Crohn's disease -- an inflammatory autoimmune condition that can affect the digestive tract, and cause ...